Smithfield Foods Inc
SFD Nasdaq Meat Packing Plants Financials FY2009–FY2025
Last close · Oct 23, 2026
$18.64
0.9%What Smithfield Foods Inc does
No business description yet.
- Legal name
- SMITHFIELD FOODS INC
- Fiscal year ends
- December 28, 2025
- Latest annual report
- 10-K · Mar 24, 2026
- Accession · CIK
- 0000091388-26-000014
0000091388
Revenue and margins
Smithfield Foods Inc had $15.5B of revenue in fiscal 2025, up 9.8% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $718M in fiscal 2025, 4.6% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Smithfield Foods Inc returned $396M to shareholders in fiscal 2025, 55% of free cash flow. The diluted share count rose 3.3%.
Balance sheet
Cash, debt and the ratios that show how comfortably Smithfield Foods Inc can carry it.
| Fiscal year end | FY15 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $705M | $547M | $687M | $943M | $1.5B |
| Debt incl. finance leases | $2.3B | — | $2.0B | $2.0B | $2.0B |
| Net debt / EBITDA | — | — | 3.5x | 0.7x | 0.3x |
| Debt / equity | 0.5x | — | 0.3x | 0.3x | 0.3x |
| Interest coverage | — | — | −0.7x | 16.9x | 31.5x |
| Current ratio | 2.4x | — | 2.0x | 2.5x | 3.0x |
| Quick ratio | 1.1x | — | 1.0x | 1.0x | 1.6x |
| Total assets | $9.9B | — | $13.3B | $11.1B | $12.2B |
| Total liabilities | $5.1B | — | $6.1B | $5.2B | $5.4B |
| Shareholders' equity | $4.8B | $7.4B | $7.2B | $5.8B | $6.8B |
| Net debt (− = net cash) | $1.6B | — | $1.3B | $1.1B | $464M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. “Plan” marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY09 | FY10 | FY11 | FY13 | FY14 | FY15 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | ✕ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Cash from operations is positive | ✓ | ✓ | ✓ | ✓ | — | — | ✓ | ✓ | ✓ |
| Return on assets rose | — | ✓ | ✕ | — | ✓ | ✕ | — | ✓ | ✕ |
| Cash from operations exceeds net income | ✓ | ✓ | ✓ | ✕ | — | — | ✓ | ✕ | ✓ |
| Debt fell relative to assets | — | ✓ | ✓ | — | ✓ | ✓ | — | ✕ | ✓ |
| Current ratio rose | — | ✕ | ✓ | — | ✕ | ✕ | — | ✓ | ✓ |
| Share count didn't rise | — | ✕ | ✓ | — | — | — | — | ✓ | ✕ |
| Gross margin rose | — | ✓ | ✕ | — | ✓ | ✓ | — | ✓ | ✓ |
| Revenue rose relative to assets | — | ✓ | ✓ | — | ✓ | ✕ | — | ✓ | ✕ |
| F-score | — / 3 | 7 / 9 | 7 / 9 | — / 3 | — / 6 | — / 6 | — / 3 | 7 / 9 | 6 / 9 |
| Accruals ratio | −4.7% | −1.2% | −2.8% | 0.1% | — | — | −5.0% | 0.3% | −0.6% |
| Altman Z'' | 3.10 | 4.58 | 4.47 | 2.59 | 3.14 | 3.33 | 3.32 | 4.27 | 4.90 |
10 years of figures
Amounts in USD. Hover a ratio’s name for its definition.
| Fiscal year | FY09 | FY10 | FY11 | FY13 | FY14 | FY15 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $11.2B | $12.2B | $13.1B | $13.2B | $15.0B | $14.4B | — | $14.6B | $14.1B | $15.5B |
| Gross profit | $730M | $1.7B | $1.5B | $1.3B | $1.8B | $1.8B | — | $889M | $1.9B | $2.1B |
| Research and development | $38.8M | $47.0M | $75.9M | $80.9M | — | — | — | $175M | $144M | $214M |
| Operating income | $62.8M | $1.1B | $723M | $519M | $932M | $794M | — | −$56.0M | $1.1B | $1.3B |
| Interest expense | $266M | $245M | $177M | $169M | — | — | — | $76.0M | $66.0M | $41.0M |
| Pretax income | — | — | — | — | — | — | — | −$129M | $1.1B | $1.3B |
| Income tax | −$113M | $236M | $172M | $46.1M | — | — | — | −$41.0M | $271M | $283M |
| Net income | −$101M | $521M | $361M | $184M | $556M | $452M | — | $17.0M | $953M | $987M |
| Diluted EPS | −$0.65 | $3.12 | $2.21 | $1.26 | — | — | — | $0.05 | $2.51 | $2.51 |
| Diluted shares | 0.16B | 0.17B | 0.16B | 0.15B | — | — | — | 0.38B | 0.38B | 0.39B |
| Cash flow | ||||||||||
| Cash from operations | $258M | $616M | $570M | $173M | — | — | — | $688M | $916M | $1.1B |
| Capital expenditure | $175M | $177M | $291M | $278M | $301M | — | — | $353M | $350M | $341M |
| Free cash flow | $83.5M | $440M | $279M | −$105M | — | — | — | $335M | $566M | $718M |
| Depreciation and amortization | $242M | $232M | $243M | $240M | — | — | — | $427M | $339M | $332M |
| Stock-based compensation | — | — | — | — | — | — | — | $0.0M | $0.0M | $9.0M |
| Acquisitions | $0.0M | $0.0M | $0.0M | $24.0M | — | — | — | — | — | — |
| Share buybacks | $0.0M | $0.0M | $190M | $386M | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | $323M | $288M | $396M |
| Dividends and buybacks | $0.0M | $0.0M | $190M | $386M | — | — | — | $323M | $288M | $396M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $451M | $375M | $324M | $193M | $434M | $705M | $547M | $687M | $943M | $1.5B |
| Total debt | $3.0B | $2.1B | $1.9B | $3.0B | $2.7B | $2.3B | — | $2.0B | $2.0B | $2.0B |
| Finance lease liabilities | — | — | — | — | — | — | — | — | $19.0M | $17.0M |
| Current assets | $3.3B | $3.3B | $3.3B | $3.5B | $3.7B | $3.7B | — | $4.9B | $4.2B | $5.2B |
| Current liabilities | $1.2B | $1.2B | $1.1B | $1.3B | $1.5B | $1.5B | — | $2.5B | $1.7B | $1.7B |
| Inventory | $1.9B | $2.0B | $2.1B | $2.3B | $2.2B | $2.1B | — | $2.5B | $2.4B | $2.3B |
| Property and equipment, net | $2.4B | $2.3B | $2.3B | $2.7B | $2.8B | $2.9B | — | — | $3.2B | $3.2B |
| Goodwill | $823M | $793M | $768M | $1.6B | $1.6B | $1.6B | $1.6B | $1.6B | $1.6B | $1.6B |
| Intangible assets | $390M | $387M | $382M | $1.4B | $1.4B | $1.4B | — | $1.3B | $1.3B | $1.3B |
| Total assets | $7.7B | $7.6B | $7.4B | $10.0B | $10.1B | $9.9B | — | $13.3B | $11.1B | $12.2B |
| Total liabilities | $5.0B | $4.1B | $4.0B | $5.7B | $5.6B | $5.1B | — | $6.1B | $5.2B | $5.4B |
| Preferred stock | $0.0M | $0.0M | $0.0M | — | — | — | — | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | $2.8B | $3.5B | $3.4B | $4.2B | $4.5B | $4.8B | $7.4B | $7.2B | $5.8B | $6.8B |
| Margins | ||||||||||
| Gross margin | 6.5% | 14.0% | 11.8% | 10.0% | 11.8% | 12.2% | — | 6.1% | 13.4% | 13.5% |
| Operating margin | 0.6% | 9.0% | 5.5% | 3.9% | 6.2% | 5.5% | — | −0.4% | 7.9% | 8.3% |
| EBITDA margin | 2.7% | 10.9% | 7.4% | 5.7% | — | — | — | 2.5% | 10.3% | 10.5% |
| Net margin | −0.9% | 4.3% | 2.8% | 1.4% | 3.7% | 3.1% | — | 0.1% | 6.7% | 6.4% |
| FCF margin | 0.7% | 3.6% | 2.1% | −0.8% | — | — | — | 2.3% | 4.0% | 4.6% |
| Returns | ||||||||||
| Return on capital | 0.9% | 16.4% | 11.4% | 5.8% | 10.8% | 9.8% | — | −0.5% | 12.1% | 13.9% |
| Return on capital employed | 1.0% | 17.2% | 11.5% | 6.0% | 10.8% | 9.5% | — | −0.5% | 12.0% | 12.4% |
| Return on equity | −3.7% | 16.5% | 10.4% | 4.3% | 12.7% | 9.7% | — | 0.2% | 14.6% | 15.6% |
| Return on assets | −1.3% | 6.8% | 4.8% | 1.8% | 5.5% | 4.5% | — | 0.1% | 7.8% | 8.5% |
| Return on tangible equity | −6.6% | 22.0% | 16.1% | 15.3% | 36.3% | 24.6% | — | 0.4% | 32.3% | 25.2% |
| Growth | ||||||||||
| Revenue growth | — | 8.9% | 7.3% | — | 13.7% | −3.9% | — | — | −3.4% | 9.8% |
| Net income growth | — | — | −30.7% | — | 202.6% | −18.7% | — | — | 5,505.9% | 3.6% |
| EPS growth | — | — | −29.2% | — | — | — | — | — | 4,920.0% | 0.0% |
| FCF growth | — | 426.5% | −36.4% | — | — | — | — | — | 69.0% | 26.9% |
| Share count change | — | 6.4% | −2.2% | — | — | — | — | — | 0.0% | 3.3% |
| Financial health | ||||||||||
| Net debt / EBITDA | 8.3x | 1.3x | 1.7x | 3.7x | — | — | — | 3.5x | 0.7x | 0.3x |
| Debt / equity | 1.1x | 0.6x | 0.6x | 0.7x | 0.6x | 0.5x | — | 0.3x | 0.3x | 0.3x |
| Interest coverage | 0.2x | 4.5x | 4.1x | 3.1x | — | — | — | −0.7x | 16.9x | 31.5x |
| Current ratio | 2.8x | 2.7x | 2.9x | 2.7x | 2.6x | 2.4x | — | 2.0x | 2.5x | 3.0x |
| Quick ratio | 1.2x | 1.1x | 1.1x | 0.9x | 1.1x | 1.1x | — | 1.0x | 1.0x | 1.6x |
| Capital allocation | ||||||||||
| Capex / revenue | 1.6% | 1.4% | 2.2% | 2.1% | 2.0% | — | — | 2.4% | 2.5% | 2.2% |
| Stock comp / revenue | — | — | — | — | — | — | — | 0.0% | 0.0% | 0.1% |
| Payouts / FCF | 0.0% | 0.0% | 67.8% | — | — | — | — | 96.4% | 50.9% | 55.2% |
| Quality scores | ||||||||||
| Piotroski F-score | — | 7.0 | 7.0 | — | — | — | — | — | 7.0 | 6.0 |
| Altman Z'' | 3.1 | 4.6 | 4.5 | 2.6 | 3.1 | 3.3 | — | 3.3 | 4.3 | 4.9 |
| Accruals ratio | −4.7% | −1.2% | −2.8% | 0.1% | — | — | — | −5.0% | 0.3% | −0.6% |
Source: SEC EDGAR XBRL filings (CIK 0000091388). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.
